A B S T R A C T Antigen-binding lymphocytes capable of binding native DNA (DNA-ABC) were identified in the peripheral blood of normal controls and patients with systemic lupus erythematosus (SLE) by autoradiography with 'I-nDNA. 12 patients with active SLE had 404±273 (mean±SD) DNA-ABC/105 lymphocytes, while 7 inactive SLE patients and 13 normals had 120+48 and 48±36, respectively. All three groups were significantly different from one another (P < 0.01). No significant correlation was detected between the quantity of anti-native DNA (nDNA) antibody and number of DNA-ABC; however, most patients with large amounts of anti-nDNA antibody had both active disease and large numbers of DNA-ABC. Numbers of DNA-ABC and lymphocytes with surface immunoglobulin (Ig) did not change significantly after anl 18-h incubation at 37°C. After depletion of B-lymphocytes by passage over bead columns coated with a complex of IgG and anti-IgG, the great majority of DNA-ABC were removed in both normal subjects and SLE patients. Labeling lymphocytes sequentially with 'JInDNA, followed by an indirect fluorescence technique for identification of surface Ig, indicated that the great majority of radiolabeled cells had surface Ig by fluorescence microscopy in four normals (average 93%) and five patients with active SLE (average 82%).
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The predominance of nDNA-sensitive B-lymphocytes in the peripheral blood of both normals and SLE patients is consistent with the concept that the induction of the anti-nDNA antibody response is due to the stimulation of preexisting nDNA-specific B lymphocytes by mechanisms other than those necessarily involving participation of nDNA-specific T lymphocytes. 
INTRODUCTION
Systemic lupus erythematosus (SLE)1 was first recognized as a disease accompanied by widespread connective tissue damage to segments of the vascular system and various serous surfaces (1) . The finding that hematoxvlin bodies were altered DNA (2) and later that LE cells contained ingested phagocytized nuclear material (3) indicated possible participation of nuclear substances in the genesis of the disease. Subsequently, the application of a variety of immunologic methods established that sera from patients with SLE contain a wide spectrum of antibodies to nuclear components, including nucleoprotein, extractable nuclear antigens, histones, and DNA itself (4) (5) (6) (7) (8) (9) (10) . Antibodies to DNA appear to play a central role in some of the immune lesions of SLE, since several lines of evidence clearly link them to renal injury. Analyses of immunoglobulin eluted from isolated SLE glomeruli have indicated high relative concentrations of anti-DNA antibody (11, 12) . A close temporal relationship between the appearance of DNA in serum and subsequent anti-DNA antibody associated with exacerbations of lupus nephritis and lowering of serum complement components (13) (14) (15) (16) (17) emphasizes the pathogenetic significance of such antibodies.
Other antibodies to nuclear components, as well as antibodies to various types of RNA (18) , may also be of importance in the pathogenesis of SLE, yet native DNA (nDNA) and anti-nDNA antibodies have clearly been defined as an important potential source of immune complexes in this disorder.
The present study was designed to examine the types of nDNA-antigen-binding cells (DNA-ABC) present in the peripheral blood of normal subjects and lupus patients. Current data support the concept that the interaction of an antigen with a specific, predetermined lymphocyte surface receptor initiates a chain of events leading to detectable antibody formation. Studies in the mouse with heterologous isotopically labeled antigens have shown that the antigen-sensitive lymphocyte is included among the ABC identified with autoradiographic techniques (19) . Previous studies identified the presence of ABC for human thyroglobulin in normal subjects (20) , as well as in chronic thyroiditis (21) . Since the former study suggested that the ABC for thyroglobulin (Tg) were primarily B lymphocytes, it is possible that self-tolerance to Tg may be due to the absence of helper T lymphocytes (22) . It was unclear from these Tg studies whether the anti-Tg response was related to the appearance of specific T helper cells in patients with chronic thyroiditis. The current study was directed to the question whether ABC capable of binding the potential autoantigen nDNA in normal subjects and lupus patients were B and/or T lymphocytes. The evidence presented here seems to indicate that loss of tolerance to nDNA in patients with SLE may be accompanied by proliferation principally of antigen-sensitive B lymphocytes.
METHODS
Subjects. Blood samples were obtained from 12 patients with active SLE, 7 patients with inactive SLE, and 13 normal subjects. The diagnosis of SLE was based on American Rheumatism Association criteria (23) . Patients with active SLE generally showed decreased serum complement (C3) and signs of activity such as synovitis, leukopenia, rash, nephritis, or serositis. Patients with inactive SLE showed normal complement and no evidence of clinical disease activity. The SLE patients generally were on a therapeutic regime that included corticosteroids (10-30 mg prednisone) and azathioprine (50-150 mg). Several untreated patients were studied, including the patients L. P. and V. C., referred to in Tables I and IV. Lymphocyte preparation. Peripheral venous blood was collected in heparinized glass tubes. Purified lymphocyte suspensions were then prepared with Ficoll-Hypaque gradient (24) Labeling of DNA with "I. The deproteinized, sonicated nDNA was labeled with 1'I as previously described (29 AnialYsis of ABC by, autoradiograplhy anid/or immun71it11o-fluiorescenzce. Lymphocyte suspeinsions were labeled successively with '"I-nD.NA and fluoresceinated goat antirabbit IgG by the indirect sandwich technique. The first step, involving the incubation with '25I-nD -A, was done as described above. The cells were waslhed three times witl FCS gradients before incubation with rabbit anti-polyvalent human Ig. The indirect sandwich technique was performed as above, except that the third wash after the incubation with fluoresceinated goat anti-rabbit IgG was done through a FCS gradient before fixation on gel slides with ethanol for 5 min. The slides were then dipped in nuclear emulsion as described above and developed [4] [5] [6] [7] [8] [9] [10] significanitly different from one another (P < 0.01).
The relationslhip between the numtber of DNA-ABC anid the quantity of anti-niD-A anitibody. No significant correlationi 'was detected between the quantity of antiniDNA antibody and the total number of lymplhocytes that bounid '251-nDNA (Fig. 2) (19) . The presence of DNA-ABC in normal subjects, demonstrated in the current study, is contrary to any simplistic theory of self-tolerance that presupposes the absence of autoantigen-sensitive lymphocytes in normal individuals. In other words, the activation of the anti-nDNA response involves the triggering of preexisting specific B lymphocytes and not merely the emergence de novo of nDNAsensitive B lymphocytes. The present data also showed increased numbers of DNA-ABC in patients with active or inactive SLE. Previous studies with human thyroglobulin have shoN-il parallel changes in ABC for human thyroglobulin in normals (20) and patients with chronic thyroiditis (21) . The increase in DNA-ABC with disease activity was not unexpected since studies in mice have clearly shown that immunization causes an increase in the number of ABC for that antigen (34) . The DNA-ABC were primarily B lymphocytes in both normal individuals and SLE patients, whether the B lymphocytes were identified by column depletion or the double-labeling technique. This would suggest that the SLE patients did not differ from normals simply because of the presence of a larger number of antigen-sensitive T lymphocytes that could enable a cooperative B-T lymphocyte anti-nDNA response to occur. One might argue that the antigen-binding techniques preferentially identify B lymphocytes, and any T lymphocytes that are DNA-ABC would evade detection. However, mouse T lymphocytes that are ABC (35) and ABC in the human thymus (36) have been identified by the autoradiographic method used in this paper. Our results provide a possible explanation for some forms of tolerance to nDNA and the induction of the anti-nDNA response in SLE. The presence of DNA-ABC in normal individuals presumably excludes the simple explanation that tolerance to nDNA is due to a lack of immunocompetent cells able to react with nDNA. If we assume that the formation of antibodies against nDNA requires the participation of two types of lymphocytes, it is possible that the absence of either B or T lymphocytes could result in self-tolerance. Since the DNA-ABC in normal people were primarily B lymphocytes, the observations suggest that T lymphocytes able to react with such B-cells are relatively scarce or absent. However, the very presence of DNA-ABC in normal subjects is of considerable interest and should temper a differentiation between normals and patients with SLE only on the basis of presence or absence of such cells. ABC detection is a subject of some controversy and appears to vary according to antigen used and methodology (37) .
Despite these technical problems, the inhibition data as shown in Table I (42) , one would expect cytophilic antibody to be shed along with membrane components. (c) Lymphocyte suspensions were washed at least tlhree times after preparation, wNhich ordinarily removes cytophilic antibody (41) . For an adherent nDNA-anti-nDNA complex to interact witlh radiolabeled nDNA, it is necessary that the complex be formed in antibody excess so that the complex would retain free anti-nDNA combining sites. However, it is clear from the present study that large numbers of DNA-ABC can exist in the absence of anti-nDNA antibody. Also dynamiic membrane changes would presumably involve the receptors for antigen-antibody complexes and result in the shedding of the complex in a relatively short time. Our longterm incubation studies showed no significant change in the number of DNA-ABC after overnight incubation at 37°C, thus making the possibility of 1"I-nDNA binding by complexes unlikely.
B lymphocytes were identified in the present study by methods that detected relatively large amounts of surface Ig. Since patients with SLE have antibodies directed against both B and T cells (43, 44) , the presence of surface Ig could theoretically include some T lymphocytes as w,vell as B lymphocytes. This potential problem was overcome in the present study by an initial incubation at 37°C, which allowed any anti-lymphocyte antibody to be shed from the cell surface (45) . The efficacy of such a preliminary short incubation in inducing complete antibody shedding was confirmed by the lack of a significant change in the number of cells with surface Ig after a furtlher, prolonged, 18-h incubationi at 370C.
Thrle i(leltificatioll of DNA\-ANBC in normal people anid patients wvith SLE was an attempt to define the cellular mechanisms involved in the induction of the antinDN:A antibody response. The resuilts reported here are (NCoMiSistenlt with 1-'iriiet's Concept (46) thlat the emiergence of a, 'forbidden clonie" of B lymniphlocytes is the primary event in the production of auitoantibodies. At least in the case of the anti-nDNA antibody response ill SLE, it appears that the response may be initiated by the stimulation of preexisting nDNA-specific B lymphocvtes by several mechanisms other than the participation of nDNA-specific helper T lymphocytes.
